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Superoxide dismutase in human erythrocytes was assayed by the inhibition of highly diluted erythrocyte lysates on 2- 
methyl-6-@-methoxyphenyl)-3,7-dihydroimidazo[l,2-a]pyrazin-3-one-dependent luminescence induced by the hypo- 
xanthine-xanthine oxidase system. Our chemiluminescence procedure gave 95-times higher sensitivity than the cyto- 
chrome c method. The concentration of superoxide dismutase in erythrocytes of Down’s syndrome patients was approx. 
1.8-times higher than that of normal humans. 
2-Methyl-6-@-methoxyphenyl)-3,7-dihydroimidazo[1,2-a]pyrazin-3-one; Chemiluminescence; Superoxide dismutase; Enzyme assay; 
Erythrocyte; Down’s syndrome 
1. INTRODUCTION 
Recently, many clinicians have directed their at- 
tention to the superoxide dismutase (SOD) levels in 
human erythrocytes of patients with various 
diseases. Cu-Zn SOD in erythrocytes of Down’s 
syndrome patients has been reported to be present 
in higher levels compared to normal humans [l-3]. 
On the other hand, erythrocytes of patients with 
Fanconi’s anemia [4], Duchenne muscle dystrophy 
[5] and rheumatic arthritis [6] have low levels of 
Cu-Zn SOD. These results were obtained using dif- 
ferent methods without regard to interference by 
protein contaminants. Oyanagui [3] has pointed 
out that a simple and sensitive method with a 
minimum of interference by proteins is needed for 
SOD assays in crude samples. 
We have reported a simple and sensitive 
luminescence method for the determination of 02 
generation in activated leukocyte systems and in 
the hypoxanthine-xanthine oxidase system, using a 
cypridina luciferin analog, 2-methyld-phenyl- 
Correspondence address: M. Nakano, College of Medical Care 
and Technology, Gunma University, Maebashi, Gunma 371, 
Japan 
3,7_dihydroimidazo[ 1,2-alpyrazin-3-one [7]. The 
present paper describes a highly sensitive lumines- 
cence method for estimating SOD concentrations 
in human erythrocytes, according to the inhibitory 
effect of erythrocyte lysates on 2-methyl-6-b- 
methoxyphenyl)-3,7-dihydroimidazo[l,2-alpyra- 
zin-3-one-dependent luminescence induced by the 
hypoxanthine-xanthine oxidase system (an 02- 
generating system). 
2. MATERIALS AND METHODS 
2.1. Chemicals and enzymes 
2 -Methyl - 6 - @ - methoxyphenyl) - 3,7 - dihydroimidazo[ 1,2 - 
alpyrazin-3-one hydrochloride (MCLA) was synthesized from 
2-amino-5-(p-methoxyphenyl)pyrazine. The detailed procedure 
will be published elsewhere [8]. The compound was dissolved in 
doubly distilled water and stored at - 80°C until needed. The 
MCLA concentration was based upon ~(430 nm) = 
9600 M-i.cm-‘. Horse heart cytochrome c (type IV), SOD 
(from bovine erythrocytes, 3000 U/mg protein) and xanthine 
oxidase (XOD, grade III) were purchased from Sigma. Hypox- 
anthine was a product of Wako. Bovine serum albumin (BSA, 
fatty acid- and globulin-free) was obtained from Sigma. To 
avoid the possible contamination of SOD (Cu-Zn SOD) with 
commercial BSA, the BSA (450 mg) was purified by passing 
through a Sephadex G-100 column (1.4 cm x 1.0 m) using 
IO mM Tris-HCl buffer at pH 7.4 as eluant. The main fraction 
obtained was then lyophilized. 
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2.2. Preparation of erythrocyte lysates 
The procedure was essentially the same as that of Oyanagui 
[3]. Erythrocyte lysates, obtained by chloroform-ethanol treat- 
ment (Tsuchihashi method), were diluted with water to a final 
concentration of l/1000 of whole blood. Further dilution was 
carried out with ethanol (0.25%). 
2.3. Assay of XOD 
Enzyme activity was determined in glycine-HCl buffer at pH 
8.8 and at 37”C, using hypoxanthine as a substrate [lo]. One 
unit of enzyme was defined as the amount of the enzyme which 
catalyzed an increase in absorbance at 290 nm of 0.001/30 min. 
2.4. Assay of SOD activity 
2.4.1. Cytochrome c method 
This followed the original method of McCord and Fridovich 
[l 11. The reaction mixture contained 1 x lo-’ M cytochrome c, 
5 x 10M5 M xanthine, XOD (350 U), SOD (10-1000 ng/ml), 
1 x 10m4 M EDTA and 50 mM potassium phosphate buffer at 
pH 7.8, in a total volume of 3 ml. The reaction was initiated by 
the addition of XOD and the absorption at 550 nm was con- 
tinuously recorded on a Hitachi spectrometer (model 200-10) at 
25°C. 
2.4.2. Chemiluminescence method 
The standard reaction mixture contained 1 x lo-’ M MCLA, 
5 x 10m5 M hypoxanthine, XOD (6.5 U), SOD (0.2-20 ng/ml) 
or none, and 50 mM Tris-HCl buffer containing 0.1 mM 
EDTA at pH 7.8, in a total volume of 3.0 ml. Chemilumines- 
cence measurement was initiated by the addition of MCLA to 
the standard incubation mixture excluding XOD, continued for 
4 min without additive and for an additional 4 min after the ad- 
dition of XOD. Chemiluminescence was measured using a 
luminescence reader (Aloka, BLRlO2) at 25°C. 
2.5. Assay of protein in erythrocyte lysates 
Protein content was determined by the method of Lowry et 
al. [12]. 
3. RESULTS AND DISCUSSION 
3. I. MCLA-dependent luminescence 
MCLA in the standard incubation mixture ex- 
cluding XOD emitted light in the visible region, as 
does CLA [7]. Such luminescence may originate 
from the auto-oxidation of MCLA, i.e. non- 
specific luminescence. When XOD was added to 
this system, the luminescence increased rapidly, 
reached a maximum at 2 min after the addition of 
XOD and remained constant for an additional 
3 min. The luminescence in the system containing 
XOD decreases with increasing SOD concentra- 
tion. However, the non-specific luminescence re- 
mains almost constant for 10 min after the 
addition of MCLA and is not significantly in- 
fluenced by SOD. These results are shown in fig. 1. 
348 
The XOD-induced luminescence (lo), expressed 
in terms of light intensity (counts/min), can be 
calculated by subtraction of the non-specific light 
intensity at 8 min after the addition of MCLA 
from the light intensity at 4 min after the addition 
of XOD. The same incubation experiments, except 
that SOD was present in both the experimental and 
control systems, were carried out and XOD- 
induced luminescence (Zi) was calculated in the 
same manner as in the absence of SOD. The per- 
cent of SOD-dependent inhibition on XOD- 
induced luminescence (lo) could be calculated from 
eqn 1, and was then plotted vs SOD concentration 
to obtain the standard curve. 
ZIJ - Zi 
% inhibition = ~ x 100 (1) 
Zo 
The SOD concentration required for 50% in- 
hibition of XOD-induced luminescence was then 
compared with that obtained by the cytochrome c 
method. As shown in fig.2A, the luminescence 
method has 95times higher sensitivity than the 
cytochrome c procedure. XOD-induced lumines- 
cence was also inhibited by purified BSA at con- 
centrations above 5 pg/ml of the reaction mixture 
(fig.2B). To ascertain the contamination of SOD 
with BSA, either a purified BSA sample or com- 
mercial BSA with or without 1 mM KCN (an in- 
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Fig. 1. Effect of SOD on MCLA-dependent luminescence. The 
standard reaction mixture with or without SOD (ng/ml) was 
used. Incubation conditions are given in the text. Arrow 
indicates the time at which MCLA or XOD was added. 
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Fig.2. (A) Comparison of the luminescence and cytochrome c 
methods. The standard and conventional reaction mixtures 
were used for the luminecence (0) and cytochrome c methods 
(A). Under the incubation conditions described in the text, 
luminescence and cytochrome c reduction were measured and 
corrected for controls. The percent inhibition by SOD at 
various concentrations was calculated in the usual way. (B) 
Effect of bovine serum albumin on XOD-induced 
luminescence. Reaction mixture essentially the same as in (A), 
except that BSA was used instead of SOD. The BSA 
concentration is expressed as &ml of the reaction mixture. 
hibitor of Cu-Zn SOD [9]) was assayed by the 
chemiluminescence method. The results obtained 
showed no contamination of SOD with the 
purified BSA and commercial BSA. Thus, BSA 
itself has some inhibitory effect on XOD-induced 
luminescence. Even if an SOD sample is con- 
taminated with BSA, albumin at less than 5 pg/ml 
would not interfere with the SOD assay by the 
luminescence method. Furthermore, no inhibitory 
effect was observed with 4 x 10e6 M glutathione, 
3 x 1O-8 M ascorbate, 10s5 M uric acid or 6 x 
10e4 M glucose. The concentrations of gluta- 
thione, ascorbate, uric acid and glucose in a 3 x 
104-fold dilution of erythrocyte lysates, correspon- 
ding to about 6 x 104-fold dilution of whole blood, 
were reported to be 8.7 x lo-*, 7.4 x lo-“, 3.8 x 
10e9 and 1 x lo-’ M, respectively [131. Protein in 
a 3 x 104-fold dilution of erythrocyte lysates 
treated according to the Tsuchihashi method cor- 
responded to 0.3 pg/ml. Thus, each of these com- 
pounds in such diluted erythrocyte lysates would 
not interfere with the SOD assay by the 
luminescence method. 
3.2. SOD in erythrocyte lysates 
To assay SOD in samples, samples corre- 
sponding to 6 x 104- and 103-fold dilutions of 
whole blood were used for the chemiluminescence 
and cytochrome c methods, respectively. Each 
sample was added to the reaction mixture, instead 
of SOD, and assayed as % inhibition on lumines- 
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Fig.3. Correlation of the luminescence method (CLM) with the 
cytochrome c method (CCM). Erythrocyte lysates, normal 
human (0) or Down’s syndrome patient (0), corresponding to 
6 x 104-fold and 1 x lo’-fold dilutions of whole blood, were 
used for the luminescence and cytochrome c methods, 
respectively. Reaction mixture and incubation conditions 
essentially as in fig.2A, except that erythrocyte lysates were 
used instead of SOD. SOD concentration in erythrocyte lysates 
was calculated with % of inhibition by known SOD, using the 
data in fig.2A, and expressed as ng/ml of the reaction mixture. 
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Table I 
Recovery test of added SOD on erythrocyte lysates by the 
luminescence method 
Expt no. Added SOD Erythrocyte lysate (ng/ml) 
(ng/ml) 
Theoretical Measured Recovery 
(@Jo) 
1 0 1.1 (100) 
0.2 1.3 1.2 92 
0.5 1.6 1.7 106 
1.0 2.1 2.1 100 
2 0 0.6 (100) 
0.2 0.8 0.76 95 
0.4 1.0 0.98 98 
0.6 1.2 1.2 100 
cence or cytochrome c reduction, as shown in 
fig.2A. Five normal humans, aged 22-40 years, 
and three Down’s syndrome patients, aged l-5 
years, donated blood which was assayed in terms 
of bovine erythrocyte Cu-Zn SOD. As shown in 
fig.3, there was a good correlation between the 
values obtained by both luminescence and cyto- 
chrome c methods. With the former, SOD in 
erythrocyte lysates corresponding to a 6 x 104-fold 
dilution of whole blood amounted to 1.0 +- 
0.14 ng/ml for normal humans and 1.83 f 0.21 
ng/ml for the patients. With the latter, SOD in 
erythrocyte lysates corresponding to a 103-fold 
dilution of whole blood was 94 + 13.2 ng/ml for 
normal humans and 155 + 22.7 ng/ml for the pa- 
tients. Using a different technique, Oyanagui [3] 
has also reported that the augmentation of SOD 
activity in erythrocytes from the patients is 56%. 
To investigate the recovery of SOD, SOD was 
loaded on erythrocyte lysates prepared in two dif- 
ferent dilutions and assayed by the chemilumines- 
cence method. This method gave good recovery 
with erythrocyte lysates (table 1). Another 
cypridina luciferin analog, 2-methyl-6-phenyl-3,7- 
dihydroimidazo[ 1,2-alpyrazin-3-one (CLA) [7], 
can also be used instead of MCLA for assaying 
SOD in erythrocyte lysates. The MCLA method is, 
however, 4.5-times more sensitive than the CLA 
method. 
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